To further validate and confirm the relevance of ATP5F1C, we next used a third completely independent database, namely the “The Metastatic Breast Cancer Project”, which includes mRNA expression profiling data (RNA Seq V2 RSEM) from the RNA-sequencing of metastatic breast cancer samples, derived from N=146 patients (Figure 4). The gene discussed is ATP5F1C; the disease is breast carcinoma.